Drug Shortage Report for MIDAZOLAM INJECTION USP
Report ID | 14497 |
Drug Identification Number | 02382377 |
Brand name | MIDAZOLAM INJECTION USP |
Common or Proper name | MIDAZOLAM |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | VIAL/AMPOULE |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-07-07 |
Estimated end date | |
Actual end date | 2018-05-24 |
Shortage status | Resolved |
Updated date | 2018-07-26 |
Company comments | Please note that the following formats are currently available: - MIDAZOLAM 5mg/mL 10x1mL GVL - MIDAZOLAM 5mg/mL 10x2mL GVL |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2018-07-26 | French | Compare |
v18 | 2018-07-26 | English | Compare |
v17 | 2018-02-20 | French | Compare |
v16 | 2018-02-20 | English | Compare |
v15 | 2018-02-20 | French | Compare |
v14 | 2018-02-20 | English | Compare |
v13 | 2017-12-15 | French | Compare |
v12 | 2017-12-15 | English | Compare |
v11 | 2017-12-15 | French | Compare |
v10 | 2017-12-15 | English | Compare |
v9 | 2017-11-21 | French | Compare |
v8 | 2017-11-21 | English | Compare |
v7 | 2017-10-23 | French | Compare |
v6 | 2017-10-23 | English | Compare |
v5 | 2017-07-21 | English | Compare |
v4 | 2017-07-19 | French | Compare |
v3 | 2017-07-19 | English | Compare |
v2 | 2017-07-03 | French | Compare |
v1 | 2017-07-03 | English | Compare |
Showing 1 to 19 of 19